Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/22551Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Gauvin, François-Pierre | - |
| dc.contributor.author | Waddell, K | - |
| dc.contributor.author | Wilson, MG | - |
| dc.date.accessioned | 2018-01-31T17:50:33Z | - |
| dc.date.available | 2018-01-31T17:50:33Z | - |
| dc.date.issued | 2017-09 | - |
| dc.identifier.citation | Gauvin FP, Waddell K, Wilson MG. Rapid synthesis: Examining the coverage of pharmacogenetic tests and use of pharmacogenetic information at the population level. Hamilton, Canada: McMaster Health Forum, 15 September 2017. | en_US |
| dc.identifier.issn | 2292-7999 | - |
| dc.identifier.uri | http://hdl.handle.net/11375/22551 | - |
| dc.description.abstract | An assessment of what is known about the coverage of pharmacogenetic tests and use of pharmacogenetic information at the population level. The rapid synthesis was conducted to address a question posed by a health system policymaker or stakeholder to the McMaster Health Forum's Rapid Response program. | en_US |
| dc.description.sponsorship | Government of British Columbia | en_US |
| dc.language.iso | en | en_US |
| dc.subject | coverage | en_US |
| dc.subject | pharmacogenetic tests | en_US |
| dc.subject | pharmacogenetic information | en_US |
| dc.subject | population | en_US |
| dc.title | Rapid Synthesis: Examining the Coverage of Pharmacogenetic Tests and Use of Pharmacogenetic Information at the Population Level | en_US |
| dc.contributor.department | None | en_US |
| Appears in Collections: | Rapid synthesis | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Examining the Coverage of Pharmacogenetic Tests and Use of Pharmacogenetic Information at the Population Level.pdf | 648.82 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
